Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Chemotactic Cytokines: Gordon Research Conference on Molecular and Cellular Mechanisms in Health and Disease
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
Effect of IFN β-1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Mitoxantrone-related acute leukemia in MS: An open or closed book?
Motor skill learning requires active central myelination.
Architecture of human mTOR complex 1.
Immune competence after alemtuzumab treatment of multiple sclerosis.
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
Refining diagnosis of multiple sclerosis with revised MRI criteria.
Gordon Research Conference on Glia Biology: Functional Interactions among Glia & Neurons
A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
Santhera's Phase III program with Catena®/Raxone® in Duchenne muscular dystrophy on track to deliver pivotal data early in 2Q 2014
Breastfeeding and multiple sclerosis.
Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
New data from ENDORSE show positive results continued over five years with TECFIDERA® (dimethyl fumarate) in a wide range of multiple sclerosis patients
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
Chronic cladribine administration increases amyloid Beta Peptide generation and plaque burden in mice.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse-Remitting Multiple Sclerosis
Adaptive myelination from fish to man.
UCSF Seminar: "Antibody Repertoire Sequencing"
RTL therapy for multiple sclerosis: a Phase I clinical study.
Novantrone (mitoxantrone HCl) Injection February 2009

Pages